Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Work
Year: 2016
Type: article
Source: The Lancet
Authors Louis Fehrenbacher, Alexander I. Spira, Marcus Ballinger, Marcin Kowanetz, Johan Vansteenkiste +13 more
Institutions Kaiser Permanente Vallejo Medical Center, Virginia Cancer Specialists, The US Oncology Network, KU Leuven, Université Toulouse III - Paul Sabatier +6 more
Cites: 31
Cited by: 2,551
Related to: 10
FWCI: 174.3
Citation percentile (by year/subfield): 100
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed